Core Scientific Rejects CoreWeave's $9 Billion Takeover Bid
Originally Published 2 months ago — by Bloomberg.com

CoreWeave's $9 billion all-stock bid for Core Scientific faces significant market skepticism and is unlikely to succeed, with less than a 30% chance of shareholder approval amid concerns over deal valuation, structure, and the company's reliance on a single customer.
